Clinical Trials Logo

Healthy Volonteers clinical trials

View clinical trials related to Healthy Volonteers.

Filter by:
  • None
  • Page 1

NCT ID: NCT05955729 Recruiting - Healthy Volonteers Clinical Trials

Effect of a Short Nap During the Night Shift of Healthcare Workers on Endothelial Function

NAP-WORK
Start date: February 19, 2024
Phase: N/A
Study type: Interventional

Night shift work is well known to cause health disruption in short and long term. It has been reported that among healthcare workers, nurses slept less than 6 h/24h. Consequences of such short sleep duration has been associated to long term issues such as endothelial dysfunction associated with cardiovascular diseases, arterial hypertension and type 2 diabetes. Countermeasures such as nap at work has potential effects on reducing the prevalence of cardiovascular diseases. However, to our knowledge, no studies have objectively investigated the effects of napping on endothelial function in a longitudinal design. Therefore, this study aims to investigate the effect of a 30 minutes on-duty nap during night work for 12 weeks on caregivers endothelial dysfunction.

NCT ID: NCT05574322 Recruiting - Healthy Athletes Clinical Trials

Efficacy of a Foot Strengthening Protocol on Sport Performance Kinetics

PRP-Pied-PERF
Start date: February 3, 2023
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to explore the effect of a foot strengthening protocol on toe flexion strength, foot deformation and morphology as well as kinetics during sprinting, cutting and jumping in healthy athletes (18-40 completed years). The study consists of a 4 weeks control period, followed by 8 weeks intervention period and 4 weeks follow up

NCT ID: NCT05113602 Completed - Healthy Volonteers Clinical Trials

Validation of the EEG Signal Quality Measured by the URGOnight Device and Comparison With a Clinical Device

SIGMA
Start date: January 26, 2021
Phase: N/A
Study type: Interventional

The electroencephalogram or EEG is a painless and non-invasive exploratory examination routinely performed in clinical and experimental medicine and has various applications. It is therefore relevant to develop application-specific EEG measurement devices. The clinical development of therapies based on brain control has led to the emergence of numerous EEG devices that aim to allow mobile, autonomous, and easy use for users. Data from the literature have proven the ability of neurofeedback (a form of biofeedback in which subjects respond to a display of their own brainwaves in order to improve their health or performance) to improve brain function in healthy or pathological subjects. These therapeutic applications are offered in hospital settings with conventional systems and in the presence of a therapist. The EEG measurement device URGOnight was developed with the aim of offering autonomous neurofeedback exercises at home. URGOnight is a portable device. It uses passive electrodes (which do not send an electric current) and so-called dry electrodes, i.e. no gel or conductive paste is required. Therefore, the SIGMA study aims to evaluate the quality of the EEG signal collected by URGOnight and compare it with an electroencephalography device commonly used in clinical and research settings. We will also evaluate the quality of the brain wave measurement usually retained in comparative studies of EEG systems.

NCT ID: NCT04461756 Completed - Healthy Volonteers Clinical Trials

Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers

Start date: November 1, 2018
Phase: Phase 1
Study type: Interventional

The primary objective of this study was to evaluate the pharmacokinetics (PK) of THC, 11-OH-THC and CBD following a single inhaled dose of PPP001 administered by vaporization. The secondary objective of this study was to determine the safety and tolerability of THC and CBD after a single inhaled dose of PPP001 administered by vaporization in healthy volunteers.